Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025)

Historic Current Taxes for Ptc Therapeutics (PTCT) over the last 7 years, with Q3 2025 value amounting to $2.9 million.

  • Ptc Therapeutics' Current Taxes fell 5131.4% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 5131.4%. This contributed to the annual value of $4.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Current Taxes is $2.9 million, which was down 5131.4% from $39.9 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Current Taxes ranged from a high of $64.6 million in Q1 2025 and a low of $618000.0 during Q2 2021
  • For the 5-year period, Ptc Therapeutics' Current Taxes averaged around $10.4 million, with its median value being $4.6 million (2022).
  • In the last 5 years, Ptc Therapeutics' Current Taxes tumbled by 7017.38% in 2021 and then skyrocketed by 342547.74% in 2025.
  • Ptc Therapeutics' Current Taxes (Quarter) stood at $1.3 million in 2021, then surged by 266.12% to $4.7 million in 2022, then plummeted by 40.11% to $2.8 million in 2023, then skyrocketed by 66.58% to $4.7 million in 2024, then plummeted by 37.74% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $39.9 million for Q2 2025, and $64.6 million during Q1 2025.